Healthcare Professionals
Information for healthcare professionals
This page is for healthcare professionals in the UK and Ireland, to provide education and knowledge about C. diff diagnosis, treatment and management.
We are currently developing our content, including factsheets. In the meantime, we have included links to pages from other organisations that provide additional information that you may find helpful.
C. diff Trust supports the diagnosis and management of C. diff in line with current clinical guidance. We do not endorse specific products or manufacturers. External links are provided for informational purposes only and do not constitute endorsement.
General information on C. diff
UK Health Security Agency (UKHSA) pages on C. difficile infection
These pages are directed at healthcare professionals and written in scientific and medical language. It should also be noted that this is currently interim guidance that is being updated.
They include sections on:
- Clinical definitions and diagnosis
- Surveillance
- Prevention
- Hand hygiene
- Dealing with increased prevalence
Centers for Disease Control and Prevention (US CDC)
General information for healthcare professionals on C. diff, written for a US audience, but much of the content is translational for the UK, with the exception of some treatment options.
Educational modules
Centers for Disease Control and Prevention (US CDC)
Healthcare resources on C. diff from the CDC.
Tillotts Pharma UK & Ireland – IDEAL
These are modules provided by a pharmaceutical manufacturer and are directed at healthcare professionals.
They include modules on:
- Diagnosis
- Treatment
- Environmental contamination
Visit Tillotts UK (for UK residents) (opens in a new tab) Visit Tillotts Ireland (for Ireland residents) (opens in a new tab)
Information on vancomycin
NICE treatment information
These guidelines talk through the recommended treatment options, including vancomycin and fidaxomicin. They also describe alternatives in life-threatening cases of infection.
These guidelines include sections on:
- Recommendations
- Antimicrobial prescribing for C. diff infection (CDI)
- Guidance
Information on fidaxomicin
Tillotts Pharma UK & Ireland
This is a pharmaceutical manufacturer website with information on C. diff and treatment, directed at healthcare professionals.
This includes:
- What Clostridioides difficile infection is
- Mechanism of action
- CDI in Inflammatory Bowel Disease (IBD)
- Granule formulation
- HCP learning resources
Visit Tillotts UK (for UK residents) (opens in a new tab) Visit Tillotts Ireland (for Ireland residents) (opens in a new tab)
This webpage was produced with financial support from Tillotts Pharma UK & Ireland. C. Diff Trust retains full editorial control over all content.